Cargando…
Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
INTRODUCTION: Cardiogenic shock refractory to standard therapy with inotropes and/or intra-aortic balloon pump is accompanied with an unacceptable high mortality. Percutaneous left ventricular assist devices may provide a survival benefit for these very sick patients. In this study, we describe our...
Autores principales: | Gaudard, Philippe, Mourad, Marc, Eliet, Jacob, Zeroual, Norddine, Culas, Geraldine, Rouvière, Philippe, Albat, Bernard, Colson, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600310/ https://www.ncbi.nlm.nih.gov/pubmed/26453047 http://dx.doi.org/10.1186/s13054-015-1073-8 |
Ejemplares similares
-
Fungal ventricular assist device infections occur in colonized patients and are associated with high mortality rate
por: Gaudard, P, et al.
Publicado: (2013) -
Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019) -
Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021) -
Pulse pressure and end-tidal carbon dioxide for monitoring low native cardiac output during veno-arterial ECLS: a prospective observational study
por: Mourad, Marc, et al.
Publicado: (2020) -
Prognosis value of dynamic variation of tissue oxygen saturation during severe cardiogenic shock
por: Gaudard, P, et al.
Publicado: (2011)